BMC Cancer

Journal Abbreviation: BMC CANCER
ISSN: 1471-2407
Publisher: BioMed Central

Publications (98)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy (2022) Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, et al. Journal article Metabolic alterations in meningioma reflect the clinical course (2021) Masalha W, Daka K, Woerner J, Pompe N, Weber S, Delev D, Krüger MT, et al. Journal article Soft tissue masses: distribution of entities and rate of malignancy in small lesions (2021) Gassert FG, Gassert FT, Specht K, Knebel C, Lenze U, Makowski MR, Von Eisenhart-Rothe R, et al. Journal article Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival (2021) Voglhuber T, Eitz KA, Oechsner M, Vogel MME, Combs SE Journal article Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (BMC Cancer, (2021), 21, 1, (920), 10.1186/s12885-021-08656-0) (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article, Erratum Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2021) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller-Hübner SKU, Traxdorf M, et al. Journal article TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article Intraventricular neuroepithelial tumors: surgical outcome, technical considerations and review of literature (2020) Aftahy AK, Barz M, Krauss P, Liesche F, Wiestler B, Combs SE, Straube C, et al. Journal article Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany (2020) Hübner H, Kurbacher CM, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Journal article